[1] PARRY S A,HODSON L.Influence of dietary macronutrients on liver fat accumulation and metabolism[J].Journal of Investigative Medicine,2017,65(8):1 102-1 115.
[2] ANGULO P.Nonalcoholic fatty liver disease//Encyclopedia of Gastroenterology[M].Amsterdam:Elsevier,2004:733-736.
[3] TILG H,MOSCHEN A R,RODEN M.NAFLD and diabetes mellitus[J].Nature Reviews Gastroenterology & Hepatology,2017,14(1):32-42.
[4] KOBA K,YANAGITA T.Health benefits of conjugated linoleic acid (CLA)[J].Obesity Research & Clinical Practice,2014,8(6):e525-e532.
[5] GAJDZIOK J,VRANÍKOVÁ B.Enhancing of drug bioavailability using liquisolid system formulation[J].Ceska a Slovenska Farmacie,2015,64(3):55-66.
[6] SUN R M,KANG X H,ZHAO Y,et al.Sirtuin 3-mediated deacetylation of acyl-CoA synthetase family member 3 by protocatechuic acid attenuates non-alcoholic fatty liver disease[J].British Journal of Pharmacology,2020,177(18):4 166-4 180.
[7] SHAN W,GAO L,ZENG W,et al.Activation of the SIRT1/p66 shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease[J].Cell Death & Disease,2015,6(7):e1833.
[8] WEN J,XU B,SUN Y C,et al.Paeoniflorin protects against intestinal ischemia/reperfusion by activating LKB1/AMPK and promoting autophagy[J].Pharmacological Research,2019,146:104308.
[9] SHI X,SUN R M,ZHAO Y,et al.Promotion of autophagosome-lysosome fusion via salvianolic acid A-mediated SIRT1 up-regulation ameliorates alcoholic liver disease[J].RSC Advances,2018,8(36):20 411-20 422.
[10] RIVA G,VILLANOVA M,CIMA L,et al.Oil red O is a useful tool to assess donor liver steatosis on frozen sections during transplantation[J].Transplantation Proceedings,2018,50(10):3 539-3 543.
[11] 钟晓怡, 林云,郭艳,等.高脂小鼠脂肪肝组织油红O特殊染色的应用[J].上海预防医学,2018,30(10):873-877.
ZHONG X Y,LIN Y,GUO Y,et al.Oil-red O special staining techniques applied in fatty liver tissue of hyperlipidemic mouse[J].Shanghai Journal of Preventive Medicine,2018,30(10):873-877.
[12] POLYZOS S A,KOUNTOURAS J,MANTZOROS C S.Obesity and nonalcoholic fatty liver disease:From pathophysiology to therapeutics[J].Metabolism,2019,92:82-97.
[13] 张配配, 李景贤,李蒙丽,等.番茄红素对非酒精性脂肪肝大鼠糖脂代谢及炎症水平的影响[J].卫生研究,2020,49(2):254-258;271.
ZHANG P P,LI J X,LI M L,et al.Effects of lycopene on metabolism of glycolipid and inflammation in non-alcoholic fatty liver disease rats[J].Journal of Hygiene Research,2020,49(2):254-258;271.
[14] MATO J M,ALONSO C,NOUREDDIN M,et al.Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease[J].World Journal of Gastroenterology,2019,25(24):3 009-3 020.
[15] PERUMPAIL B J,KHAN M A,YOO E R,et al.Clinical epidemiology and disease burden of nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2017,23(47):8 263-8 276.
[16] CHEN S C,LIN Y H,HUANG H P,et al.Effect of conjugated linoleic acid supplementation on weight loss and body fat composition in a Chinese population[J].Nutrition,2012,28(5):559-565.
[17] YANG J M,SUN Y,WANG M,et al.Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease[J].World Journal of Gastroenterology,2019,25(34):5 105-5 119.
[18] LEHNEN T E,DA SILVA M R,CAMACHO A,et al.A review on effects of conjugated linoleic fatty acid (CLA) upon body composition and energetic metabolism[J].Journal of the International Society of Sports Nutrition,2015,12:36.
[19] MASLAK E,BUCZEK E,SZUMNY A,et al.Individual CLA isomers,c9t11 and t10c12,prevent excess liver glycogen storage and inhibit lipogenic genes expression induced by high-fructose diet in rats[J].Biomed Research International,2015,2015:535 982.
[20] 祝彤彤, 张辉珍,王晓滨,等.共轭亚油酸甘油酯对大鼠血清脂肪酸组成影响的研究[J].现代生物医学进展,2016,16(15):2 842-2 846.
ZHU T T,ZHANG H Z,WANG X B,et al.Effects of conjugated linoleic acid glycerides on the composition of serum fatty acid in rats[J].Progress in Modern Biomedicine,2016,16(15):2 842-2 846.
[21] NEUBAUER M P,POEHLMANN M,FERY A.Microcapsule mechanics:From stability to function[J].Advances in Colloid and Interface Science,2014,207:65-80.
[22] LÓPEZ-LLUCH G,DEL POZO-CRUZ J,SÁNCHEZ-CUESTA A,et al.Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization[J].Nutrition,2019,57:133-140.
[23] 刘明, 徐维锋,张显仁,等.共轭亚油酸甘油酯的储存稳定性研究[J].中国油脂,2012,37(10):50-52.
LIU M,XU W F,ZHANG X R,et al.Storage stability of conjugated linoleic acid glyceride[J].China Oils and Fats,2012,37(10):50-52.
[24] YOUNOSSI Z,ANSTEE Q M,MARIETTI M,et al.Global burden of NAFLD and NASH:Trends,predictions,risk factors and prevention[J].Nature Reviews Gastroenterology & Hepatology,2018,15(1):11-20.
[25] POLYZOS S A,KOUNTOURAS J,MANTZOROS C S.Adipose tissue,obesity and non-alcoholic fatty liver disease[J].Minerva Endocrinologica,2017,42(2):92-108.
[26] ALEXANDER M,LOOMIS A K,VAN DER LEI J,et al.Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD:Real-world study of 18 million patients in four European cohorts[J].BMC Medicine,2019,17(1):95.
[27] MA M J,DUAN R,ZHONG H,et al.The crosstalk between fat homeostasis and liver regional immunity in NAFLD[J].Journal of Immunology Research,2019,2019:3954890.
[28] BYRNE C D,TARGHER G.NAFLD:A multisystem disease[J].Journal of Hepatology,2015,62(1):S47-S64.
[29] RINELLA M E,SANYAL A J.Management of NAFLD:A stage-based approach[J].Nature Reviews Gastroenterology & Hepatology,2016,13(4):196-205.
[29] RINELLA M E,SANYAL A J.Management of NAFLD:A stage-based approach[J].Nature Reviews.Gastroenterology & Hepatology,2016,13(4):196-205.